Literature DB >> 10957656

The consequences of a failed femoropopliteal bypass grafting: comparison of saphenous vein and PTFE grafts.

M R Jackson1, T P Belott, T Dickason, W J Kaiser, J G Modrall, R J Valentine, G P Clagett.   

Abstract

OBJECTIVES: Although there are numerous reports comparing saphenous vein (SV) and polytetrafluoroethylene (PTFE) with respect to the patency rates for femoropopliteal bypass grafts, the clinical consequences of failed grafts are not as well described. This study compares the outcomes of failed SV and PTFE grafts with a specific emphasis on the degree of acute limb ischemia caused by graft occlusion.
METHODS: Over a 6-year period, 718 infrainguinal revascularization procedures were performed, of which 189 were femoropopliteal bypass grafts (SV, 108; PTFE, 81). Society for Vascular Surgery/International Society for Cardiovascular Surgery (SVS/ISCVS) standardized runoff scores were calculated from preoperative arteriograms. Clinical categories of acute limb ischemia resulting from graft occlusion were graded according to SVS/ISCVS standards (I, viable; II, threatened; III, irreversible). Primary graft patency and limb salvage rates at 48 months were calculated according to the Kaplan-Meier method.
RESULTS: Patients were well matched for age, sex, and comorbidities. Chronic critical ischemia was the operative indication in most cases (SV, 82%; PTFE, 80%; P =.85). Runoff scores and preoperative ankle-brachial index measurements were similar for the two groups (SV, 6.0 +/- 2.5 [SD] and 0.51 +/- 0.29; PTFE, 5.3 +/- 2.8 and 0.45 +/- 0.20; P =.06 and P =.12). The distal anastomosis was made below the knee in 60% of SV grafts and 16% of PTFE grafts (P <.001). Grade II ischemia was more likely to occur after occlusion of PTFE grafts (78%) than after occlusion of SV grafts (21%; P =.001). Emergency revascularization after graft occlusion was required for 28% of PTFE failures but only 3% of SV graft failures (P <.001). Primary graft patency at 48 months was 58% for SV grafts and 32% for PTFE grafts (P =.008). Limb salvage was achieved in 81% of SV grafts but only 56% of PTFE grafts (P =.019).
CONCLUSIONS: Patients undergoing femoropopliteal bypass grafting with PTFE are at greater risk of ischemic complications from graft occlusion and more frequently require emergency limb revascularization as a result of graft occlusion than patients receiving SV grafts. Graft patency and limb salvage are superior with SV in comparison with PTFE in patients undergoing femoropopliteal bypass grafting.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10957656     DOI: 10.1067/mva.2000.108634

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  16 in total

Review 1.  Cardiovascular Bio-Engineering: Current State of the Art.

Authors:  Teresa Simon-Yarza; Isabelle Bataille; Didier Letourneur
Journal:  J Cardiovasc Transl Res       Date:  2017-03-06       Impact factor: 4.132

2.  A Multicenter Predictive Score for Amputation-Free Survival for Patients Operated on with an Heparin-Bonded ePTFE Graft for Critical Limb Ischemia.

Authors:  Walter Dorigo; Gabriele Piffaretti; Raffaele Pulli; Patrizio Castelli; Carlo Pratesi
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

3.  Comparison of long-term results of above-the-knee femoro-popliteal bypass with autogenous vein and polytetrafluoroethylene grafts.

Authors:  Seon-Hee Heo; Yang-Jin Park; Shin-Young Woo; Dong-Ik Kim; Young-Wook Kim
Journal:  Ann Surg Treat Res       Date:  2014-12-26       Impact factor: 1.859

4.  Critical Limb Ischemia.

Authors:  David L. Dawson; Ryan T. Hagino
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-06

Review 5.  Basic data related to surgical infrainguinal revascularization procedures: a twenty year update.

Authors:  Kenneth R Ziegler; Akihito Muto; Sammy D D Eghbalieh; Alan Dardik
Journal:  Ann Vasc Surg       Date:  2011-04       Impact factor: 1.466

6.  [Omniflow-IITM for critical limb ischemia : Long-term results].

Authors:  F Dünschede; M Youssef; J Stabrauskaite; S Ahmed; C Espinola-Klein; B Dorweiler; C-F Vahl
Journal:  Chirurg       Date:  2017-03       Impact factor: 0.955

Review 7.  Remote endarterectomy: an alternative to surgical bypass.

Authors:  A R Chandrashekar; Rajendra Prasad B; Sanjay C Desai; A H Harsha
Journal:  Indian J Surg       Date:  2012-09-28       Impact factor: 0.656

8.  Mechanically tuned vascular graft demonstrates rapid endothelialization and integration into the porcine iliac artery wall.

Authors:  Kaspars Maleckis; Alexey Kamenskiy; Eliezer Z Lichter; Rebecca Oberley-Deegan; Yuris Dzenis; Jason MacTaggart
Journal:  Acta Biomater       Date:  2021-02-04       Impact factor: 8.947

9.  The effects of PPARγ agonist rosiglitazone on neointimal hyperplasia in rabbit carotid anastomosis model.

Authors:  Mehmet Guzeloglu; Buket Reel; Soner Atmaca; Alper Bagrıyanık; Eyup Hazan
Journal:  J Cardiothorac Surg       Date:  2012-06-20       Impact factor: 1.637

10.  Expandable external support device to improve Saphenous Vein Graft Patency after CABG.

Authors:  Yanai Ben-Gal; David P Taggart; Mathew R Williams; Eyal Orion; Gideon Uretzky; Rona Shofti; Shmuel Banai; Liad Yosef; Gil Bolotin
Journal:  J Cardiothorac Surg       Date:  2013-05-06       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.